Sterling Capital Management LLC trimmed its holdings in Humana Inc. (NYSE:HUM – Free Report) by 43.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,155 shares of the insurance provider’s stock after selling 3,167 shares during the quarter. Sterling Capital Management LLC’s holdings in Humana were worth $720,000 as of its most recent SEC filing.
A number of other institutional investors have also added to or reduced their stakes in the stock. Montag A & Associates Inc. boosted its position in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the last quarter. CoreCap Advisors LLC increased its holdings in Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after acquiring an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac purchased a new stake in Humana in the 4th quarter worth $27,000. Reflection Asset Management purchased a new stake in Humana in the 4th quarter worth $29,000. Finally, Rosenberg Matthew Hamilton boosted its holdings in shares of Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 68 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several brokerages have recently issued reports on HUM. The Goldman Sachs Group lifted their target price on Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a report on Thursday, April 30th. William Blair assumed coverage on Humana in a report on Wednesday, May 20th. They set an “outperform” rating for the company. TD Cowen lifted their price objective on Humana from $173.00 to $211.00 and gave the stock a “hold” rating in a research note on Friday, May 1st. Raymond James Financial reaffirmed an “outperform” rating and set a $260.00 price objective on shares of Humana in a report on Friday, May 1st. Finally, Royal Bank Of Canada reiterated a “sector perform” rating on shares of Humana in a research report on Monday, June 1st. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, Humana presently has a consensus rating of “Hold” and an average target price of $293.09.
Humana Price Performance
HUM opened at $409.92 on Thursday. The firm has a market capitalization of $49.22 billion, a PE ratio of 43.84, a price-to-earnings-growth ratio of 2.26 and a beta of 0.71. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The business’s 50-day moving average is $314.71 and its two-hundred day moving average is $248.64. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $414.82.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. During the same period in the prior year, the firm posted $11.58 earnings per share. The company’s quarterly revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Research analysts anticipate that Humana Inc. will post 9.04 earnings per share for the current fiscal year.
Humana Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is 37.86%.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Further Reading
- Five stocks we like better than Humana
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
